Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 358 | 777 | 931 | 630 | 524 |
| Income taxes - deferred | -295 | -116 | -95 | -97 | -246 |
| Accounts receivable | -101 | 823 | -154 | -92 | -408 |
| Accounts payable and accrued liabilities | 563 | N/A | N/A | N/A | N/A |
| Other Working Capital | 488 | 1,248 | 125 | -676 | -174 |
| Other Operating Activity | -3,434 | -4,215 | -4,035 | -4,152 | -4,572 |
| Operating Cash Flow | $-2,422 | $-1,483 | $-3,228 | $-4,387 | $-4,876 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,226 | -525 | -661 | -2,064 | -407 |
| Net Acquisitions | N/A | N/A | 0 | -1,058 | -337 |
| Purchase Of Investment | N/A | N/A | 0 | -200 | 0 |
| Sale Of Investment | N/A | 0 | 11 | 148 | 162 |
| Investing Cash Flow | $-1,226 | $-525 | $-650 | $-3,175 | $-583 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -649 | 582 | N/A | 0 | 286 |
| Debt Repayment | -117 | -136 | -220 | -164 | -88 |
| Common Stock Repurchased | N/A | 0 | -89 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 102 | 50 | 253 |
| Financing Cash Flow | $-766 | $445 | $-207 | $-114 | $452 |
| Exchange Rate Effect | 47 | 29 | -29 | 69 | -84 |
| Beginning Cash Position | 12,838 | 14,372 | 18,487 | 26,094 | 31,185 |
| End Cash Position | 8,471 | 12,838 | 14,372 | 18,487 | 26,094 |
| Net Cash Flow | $-4,414 | $-1,563 | $-4,086 | $-7,676 | $-5,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,422 | -1,483 | -3,228 | -4,387 | -4,876 |
| Capital Expenditure | -1,226 | -531 | -694 | -2,064 | -407 |
| Free Cash Flow | -3,648 | -2,014 | -3,922 | -6,451 | -5,283 |